The Peak Surgery System provides for a unique balance between precision cutting and bleeding control.  The technology enables a surgeon to:

  1. -Cut precisely through any type of tissue (including muscle)

  2. -Fine tune the amount of bleeding control to the target tissue; effectively minimizing thermal damage.

  3. -Operate at 50% lower temperatures than traditional electrosurgery technology, going as low as 50º C.

  4. -Utilize about 50% the amount of watts than traditional electrosurgery technology.

  5. -Maintain performance in both a wet and dry field.


Studies have revealed:

-Reduced scarring

-Reduced inflammation

-Stronger surgical incision wound healing.

-Increased cutting speed and precision.

-Significantly reduced eschar build up

-Little to no surgical smoke while in the cut mode.

-Less cutting force required than a slapel and traditional    electrosurgery.




























 

OVERVIEW

In preclinical study data presented at the American College of Surgeons Annual Clinical Meeting in October 2007, surgical incision wounds created by the PlasmaBlade healed as quickly as a scalpel-- and, after 6 weeks, were three times stronger than ones made by the traditional electrosurgery technology.












The PlasmaBlade illustrated:

  1. -60% less bleeding than a scalpel, with no increase in collateral damage.

  2. -75% less thermal damage than traditional electrosurgery.

  3. -Positive wound healing profile similar to the cold scalpel.

  4. -Stronger surgical incision wound healing than traditional electrosurgery techniques.






By observing the above graphs (where the  green is the PlasmaBlade, grey is the scalpel, and the blue is traditional electrosurgery), wounds from the PlasmaBlade healed as quickly as the scalpel, and after 6 weeks, were 3 times stronger than traditional electrosurgery. In addition, the PlasmaBlade showed significantly reduced levels of inflammatory cells 1 to 6 weeks after surgery.  At 6 weeks, PlasmaBlade incisions had statistically significant lower levels of inflammatory cells which provides for a direct correlation to the amount of damaged tissue present.

Scar formation was comparable between the scalpel and PlasmaBlade incisions, but was significantly less than traditional electrosurgery incisions (p=0.02 and 0.03) respectively.
















PEAK Surgical is planning on additional preclinical and clinical studies and is exploring the applicability of its technology across numerous surgical field, including general, cardiothoracic, gynecologic, plastic and reconstructive, and neurosurgery.  The company believes that the developed technology may have applications in more than two million surgical procedures each year, thus having a significant impact on the healthcare industry.